Vol 54, No 6 (2020)
Invited Editorial
Published online: 2020-12-31
Unravelling the colourful tapestry of hereditary transthyretin amyloid polyneuropathy in Poland
Abstract
Not available
References
- Plante-Bordeneuve V. Transthyretin familial amyloid polyneuropathy: an update. J Neurol. 2018; 265(4): 976–983.
- Schmidt HH, Waddington-Cruz M, Botteman MF, et al. Estimating the global prevalence of transthyretin familial amyloid polyneuropathy. Muscle Nerve. 2018; 57(5): 829–837.
- Hawkins PN, Ando Y, Dispenzeri A, et al. Evolving landscape in the management of transthyretin amyloidosis. Ann Med. 2015; 47(8): 625–638.
- Cortese A, Vegezzi E, Lozza A, et al. Diagnostic challenges in hereditary transthyretin amyloidosis with polyneuropathy: avoiding misdiagnosis of a treatable hereditary neuropathy. J Neurol Neurosurg Psychiatry. 2017; 88(5): 457–458.
- Planté-Bordeneuve V, Ferreira A, Lalu T, et al. Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP). Neurology. 2007; 69(7): 693–698.
- Adams D, Lozeron P, Lacroix C. Amyloid neuropathies. Curr Opin Neurol. 2012; 25(5): 564–572.
- Lipowska M, Drac H, Rowczenio D, et al. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland- genetic and clinical presentations. Neurol Neurochir Pol. ; 2020.
- Gawor M, Holcman K, Franaszczyk M, et al. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis. Cardiol J. 2020 [Epub ahead of print].
